Brazzaville, Congo 5-7 March 2014

20
Brazzaville, Congo 5-7 March 2014 5th Inter-Agency Meeting on Coordination and Harmonization of HIV/AIDS, TB and Malaria Strategies

description

5th Inter-Agency Meeting on Coordination and Harmonization of HIV/AIDS, TB a nd Malaria Strategies. Brazzaville, Congo 5-7 March 2014. Treatment 2015 launch. The agreed target…. .. a nd focusing on treatment is strategic. Treatment continues to expand. 2003. 2015. - PowerPoint PPT Presentation

Transcript of Brazzaville, Congo 5-7 March 2014

Page 1: Brazzaville, Congo 5-7 March 2014

Brazzaville, Congo5-7 March 2014

5th Inter-Agency Meeting on Coordination and Harmonizationof HIV/AIDS, TB and Malaria Strategies

Page 2: Brazzaville, Congo 5-7 March 2014

Treatment 2015 launch

Page 3: Brazzaville, Congo 5-7 March 2014

The agreed target…

Page 5: Brazzaville, Congo 5-7 March 2014

2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 20150

15,000,000

2012 20152003

Treatment continues to expand

Page 6: Brazzaville, Congo 5-7 March 2014

Gaps in global antiretroviral coverage under the 2010 and 2013 WHO HIV treatment guidelines

Eligible but not receiving treatment

Eligible and receiving treatment

Total eligible:

*Numbers of people receiving treatment in December 2012 versus

(a) the numbers eligible in December 2012 under the 2010 WHO guidelines;

(b) the numbers eligible in December 2013, under the 2013 WHO guidelines.

18,563,000

0%

50%

100%28,600,000

2010 guidelines* 2013 guidelines*

14,000,000

66%39%

Page 7: Brazzaville, Congo 5-7 March 2014

Source: UNAIDS estimates 2013

Gap in antiretroviral coverage varies within Africa

Page 8: Brazzaville, Congo 5-7 March 2014

The agreed target is still ambitious…

…and is a stepping stone towards treatment for all in need

Page 9: Brazzaville, Congo 5-7 March 2014

UNAIDS PCB calls for new targets

• Encompass new science• Drive progress• Guide action beyond 2015• Ultimately aspire to end the AIDS epidemic

Page 10: Brazzaville, Congo 5-7 March 2014

Challenges ahead: 1- Societal

• Lack of knowledge of HIV status• Punitive policies and laws• Stigma and discrimination

Page 11: Brazzaville, Congo 5-7 March 2014

Challenges ahead: 2- diverse facility level costs

*Republic of South Africa: costs include updated antiretroviral prices, which were renegotiated by the RSA government in early 2010 and are 53% lower than those observed during the costing period.

US

$

Average

Maximum

Minimum

US$136US$186

US$232US$278

US$682

Malawi Ethiopia Rwanda Zambia RSA$0

$100

$200

$300

$400

$500

$600

$700

$800

$900

South Africa*

Page 12: Brazzaville, Congo 5-7 March 2014

Challenges ahead: 3- treatment cascade

Sources: 1. UNAIDS 2012 estimates; 2. Demographic and Health Surveys, 2007–2011 (www.measuredhs.com); 3. Kranzer, K., van Schaik, N., et al. (2011), PLoS ONE; 4. GARPR 2012; 5. Barth R E, van der Loeff MR, et al. (2010), Lancet Infect Disease.

Notes: No systematic data are available for the proportion of people living with HIV who are linked to care, although this is a vital step to ensuring viral suppression in the community.

Page 13: Brazzaville, Congo 5-7 March 2014

Challenges ahead: 4- delivery systems

Relative likelihood of HIV-positive adults (15-49 years) accessing antiretroviral therapy due to the distance from their nearest primary healthcare facility. Source: Location, Location: Connecting people faster to HIV services, UNAIDS; Geneva, 2013

Page 14: Brazzaville, Congo 5-7 March 2014

Challenges ahead: 5- Key populations and partnersa substantial share of new infections

Nigeria 51%Kenya

about 33%Mozambique more than

25% Morocco 80% Dominican Rep. 47% Peru 65%

Page 15: Brazzaville, Congo 5-7 March 2014

Expected impact of HIV treatment in survival of a 20 years old person living with HIV in a high income setting (different periods)

HIV treatment can normalize survival

Page 16: Brazzaville, Congo 5-7 March 2014

What we can achieve

Projected annual AIDS-related deaths, assuming scale up to 95% coverage by 2020

Page 17: Brazzaville, Congo 5-7 March 2014

Expanding access to ART is a smart investment: Case of South Africa

Source: Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050. PLoS ONE 7(2):e30216

Page 18: Brazzaville, Congo 5-7 March 2014

With international support, universal access to ART is at reach in low- and middle income countries

MalawiLesotho

ZimbabweMozambique

BurundiUganda

Central African Rep.Tanzania

ZambiaSwaziland

KenyaLiberia

TogoRwanda

Sierra LeoneCameroon

ChadGuinea-Bissau

Côte d’IvoireBotswana

HaitiGuinea

NamibiaDjiboutiNigeria

South AfricaBurkina Faso

NigerBenin

EritreaGhana

MaliCambodia

BelizeMyanmarSenegal

AR

T c

osts

as

a pe

rcen

tage

of

GD

P

0 1 2 3 4 5 6 7 8%

2% – 5%

5% – 8%

0.1% – 1%

1% – 2%

Source: Williams arXiv 2012: http://arxiv.org/abs/1206.6774

Page 19: Brazzaville, Congo 5-7 March 2014

The tasks ahead

Source: Terhorst, D & Schmid, G., WHO 2006

Country consultations Regional consultations Dialogue with key

strategic partners Global consensus

meeting

Consultations(Countries, regions, ad hoc)

Develop instruments(to support partners)

Modelling Costing Supply forecast Testing campaign

Demand Resources Progress

Monitoring and evaluation

Page 20: Brazzaville, Congo 5-7 March 2014

Making it work: The African Union Roadmap

• Sustainable financing models

• Access to medicines – Local production and regulatory harmonization

• Leadership, governance and oversight